Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
13381
Initial transport rate of [<sup>3</sup>H]-hypoxanthine of PhZ mutants (V%).
Published 2024“…<p>AzgA, PhZwt and mutant strains were included. 100% is considered the transport rate of the PhZwt strain. …”
-
13382
The Phosphate Transporter PiT1 (Slc20a1) Revealed As a New Essential Gene for Mouse Liver Development
Published 2010“…</p><h3>Methodology/Principal Findings</h3><p>To determine the <em>in vivo</em> function of <em>PiT1</em>, we generated an allelic series of <em>PiT1</em> mutations in mice by combination of wild-type, hypomorphic and null <em>PiT1</em> alleles expressing from 100% to 0% of <em>PiT1</em>. …”
-
13383
Fig 6 -
Published 2020“…<p>(a) Skin. Mouse in the G5 group (betamethasone) (H&E) (Bar = 20–100 μm). …”
-
13384
-
13385
A Frequent <em>PNPLA3</em> Variant Is a Sex Specific Disease Modifier in PSC Patients with Bile Duct Stenosis
Published 2013“…DS patients showed markedly decreased survival (p = 0.004) when carrying the I148M variant (I148M: mean 13.8 years; 95% confidence interval: 11.6–16.0 vs. wildtype: mean 18.6 years; 95% confidence interval: 16.3–20.9) while there was no impact on survival in patients without a DS (p = 0.87). …”
-
13386
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Act...
Published 2016“…We propose that careful classification of a patient’s breast cancer subtype is central to effectively targeting STAT3/5 as a therapeutic means of treating breast cancer, particularly given that xCT is emerging as an important biomarker of aggressive cancers.…”
-
13387
RB1CC1 binds to and activates the promoters of <i>RB1</i>, <i>p16</i> and <i>p21</i>, cooperating with p53 and/or hSNF5.
Published 2010“…The values indicate the means ± standard errors from quadruplicate experiments. …”
-
13388
-
13389
Vacancy Engineering Strategy Releases the Electrocatalytic Oxygen Evolution Reaction Activity of High-Entropy Oxides
Published 2025“…Herein, we demonstrate that the kinetic limitation of the OER imposed by a conventional adsorbate evolution mechanism can be successfully overcome through activating lattice oxygen in the electrocatalyst. …”
-
13390
Vacancy Engineering Strategy Releases the Electrocatalytic Oxygen Evolution Reaction Activity of High-Entropy Oxides
Published 2025“…Herein, we demonstrate that the kinetic limitation of the OER imposed by a conventional adsorbate evolution mechanism can be successfully overcome through activating lattice oxygen in the electrocatalyst. …”
-
13391
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”
-
13392
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”
-
13393
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”
-
13394
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”
-
13395
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”
-
13396
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”
-
13397
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”
-
13398
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”
-
13399
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”
-
13400
Electrostatic Interaction-Based High Tissue Adhesive, Stretchable Microelectrode Arrays for the Electrophysiological Interface
Published 2022“…Current adhesives form tough adhesion to tissues by covalent interaction, which decreases the biocompatibility of the adhesives. Here, we fabricate a strong electrostatic adhesive (noncovalent interaction), highly conformal, stretchable microelectrode arrays (MEAs) for the electrophysiological interface. …”